Annexon (ANNX) vs Apnimed (APMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Annexon is the larger company by market cap ($760.2 million vs $751.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANNX | APMD |
|---|---|---|
| Share price | $4.01 | $18.04 |
| Market cap | $760.21M | $751.02M |
| 1-day change | -0.50% | -3.27% |
| YTD return | -20.12% | — |
| 1-year return | +30.62% | — |
| 5-year return | -81.77% | — |
| P/E ratio (TTM) | — | 2.50 |
| EPS (TTM) | $-1.13 | $7.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.18 | $35.29 |
| 52-week low | $2.54 | $16.12 |
| Distance from 52-week high | -44.15% | -48.88% |
| Average volume | 3.19M | 558.59K |
| Shares outstanding | 189.58M | 41.63M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ANNX vs APMD FAQ
Which is bigger, Annexon or Apnimed?
Annexon (ANNX) is larger, with a market capitalization of $760.21M compared with $751.02M for Apnimed (APMD).
Are Annexon and Apnimed in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.